Allen Andrew R — SEC Form 4 filings
SEC reporting owner CIK 1374539. 6 Form 4 filings on record with FilingPulse; latest filed 2026-06-18.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-02-05 to 2026-06-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 24,263 shares, $18,156 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 24,263 shares @ $0.75 ($18,156) in Gritstone bio, Inc., filed 2024-05-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Gritstone bio, Inc. (GRTS) | PRESIDENT AND CEO, Director | 3 | — | 1 leg · 24,263 sh · $18,156 | 6 |
| Cullinan Therapeutics, Inc. (CGEM) | Director | 2 | — | — | 2 |
| Adaptimmune Therapeutics PLC (ADAP) | Director | 1 | — | — | 1 |
Form 4 filings — Allen Andrew R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-18 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 21,781 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 79,456 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Adaptimmune Therapeutics PLC (ADAP) | Grant/award (A): 660,000 (derivative) @ $0 | EDGAR |
| 2024-06-26 | 4 | Gritstone bio, Inc. (GRTS) | Gift (G): 325,000 @ $0 · Gift (G): 325,000 @ $0 | EDGAR |
| 2024-05-17 | 4 | Gritstone bio, Inc. (GRTS) | Grant/award (A): 47,873 @ $0 · Sale (S): 24,263 @ $0.75 · Grant/award (A): 615,000 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Gritstone bio, Inc. (GRTS) | Grant/award (A): 105,000 @ $0 · Grant/award (A): 615,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1374539 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →